|
|
Volumn 6, Issue 1, 2011, Pages 3-4
|
|
Survival advantage in CLL with frontline FCR therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
FLUDARABINE;
RITUXIMAB;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER PATIENT;
CANCER SURVIVAL;
CHRONIC LYMPHATIC LEUKEMIA;
HUMAN;
OPEN STUDY;
PROGRESSION FREE SURVIVAL;
TREATMENT OUTCOME;
|
|
EID: 79551472573
PISSN: 15588211
EISSN: 1558822X
Source Type: Journal
DOI: 10.1007/s11899-010-0074-6 Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
